来自官方财务报表的收入、利润与现金流历史。
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
| 利润表 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| 总收入 | $1.4B | $1.3B | $693M | $532M | $321M | $258M | $188M | $62M |
| 毛利 | $1.0B | $886M | $381M | $286M | $130M | $84M | $29M | $16M |
| 毛利率% | 69.9% | 69.6% | 55.0% | 53.8% | 40.6% | 32.4% | 15.3% | 25.9% |
| 营业利润（EBIT） | ($261M) | ($239M) | ($691M) | ($196M) | ($265M) | ($244M) | ($193M) | ($120M) |
| 营业利润率% | -18.2% | -18.8% | -99.7% | -36.9% | -82.8% | -94.5% | -102.9% | -193.0% |
| 净利 | ($254M) | ($245M) | ($706M) | ($214M) | ($290M) | ($259M) | ($210M) | ($115M) |
| 净利润率 % | -17.8% | -19.3% | -101.8% | -40.3% | -90.4% | -100.5% | -111.6% | -185.2% |
| EBITDA | — | ($222M) | ($610M) | ($133M) | ($237M) | ($220M) | ($169M) | ($100M) |
| 每股收益（EPS） | $-1.44 | $-1.41 | $-4.35 | $-1.39 | $-1.71 | $-1.53 | $-1.24 | $-0.72 |
| 已发行股数 (M) | — | 174M | 162M | 154M | 170M | 170M | 170M | 161M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 TEM 交互式查看器。 /companies/us/TEM
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms